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Objectives: Postmortem examination of temporal bones of Ménière’s 
disease patients consistently show dilated endolymphatic spaces of the 
inner ear, for which the term endolymphatic hydrops has been coined. 
During the past decade, magnetic resonance imaging techniques for 
the inner ear appeared, advancing the diagnosis of Ménière’s disease. 
They require, however, a field-strength of at least 3 T, are costly and not 
universally available. Alternative, noninvasive, cost-effective tests with 
high sensitivity and specifity for endolymphatic hydrops are desirable. 
In this study, we test the suitability of distortion product otoacoustic 
emissions (DPOAEs) for endolymphatic hydrops detection. Previous 
measurements of the commonly recorded cubic DPOAEs mainly reg-
ister cochlear hearing loss and are not specific for Ménière’s disease. 
Simultaneous recordings of cubic and quadratic DPOAEs might be more 
suitable to detect endolymphatic hydrops, because both DPOAE orders 
react differently to changes of the cochlear operating point as they might 
occur in Ménière’s disease patients.
Design: Cubic and quadratic DPOAEs were recorded in normal-hearing 
participants (N = 45) and in the affected and unaffected ears of patients 
with a diagnosis of definite Ménière’s disease (N = 32). First, to assess 
the integrity of DPOAE-generating mechanisms, cubic DPOAE-grams were 
obtained with primary tone frequencies f2 between 1 and 8 kHz with primary 
tone levels l1 = 60 dB SPL and l2 = 50 dB SPL, and a fixed primary tone 
frequency ratio of 1.22. Then, cubic and quadratic DPOAEs were simultane-
ously recorded with primary tone levels l1 = l2 = 65 dB SPL and at primary 
tone frequencies f2 = 4 and 5 kHz, where f1 was successively varied such 
that the ratio f2/f1 ranged between 1.1 and 1.6 in 0.04 steps while quadratic 
and cubic DPOAE levels were extracted from the same recording.
Results: Cubic DPOAEs were significantly reduced in the affected ears 
of Ménière’s disease patients, and slightly reduced in the unaffected ears 
of Ménière’s disease patients, relative to the ears of normal-hearing par-
ticipants. In contrast, no significant changes could be seen in quadratic 
DPOAEs across the ears of normal-hearing participants and Ménière’s 
disease patients.
Conclusions: We could identify a relatively good preservation of qua-
dratic DPOAE levels in relation to a reduction of cubic DPOAE levels 
as a potential noninvasive diagnostic approach in the early stage of 
suspected Ménière’s disease. Future studies validating the differential 
diagnostic power of this parameter in control groups with nonhydropic 
forms of hearing loss are warranted.
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INTRODUCTION
Ménière’s disease (MD) is a chronic disease of the auditory 
and vestibular periphery affecting about 50/100,000 in the gen-
eral population (review: Sajjadi & Paparella 2008), with reports 
of up to 500/100,000 (Havia et al. 2005). Patients suffer from epi-
sodes of vertigo, (low-frequency) hearing loss and tinnitus, often 
accompanied by a feeling of aural fullness (Monsell et al. 1995). 
Postmortem examination of temporal bones of MD patients con-
sistently show dilated endolymphatic spaces of the inner ear, for 
which the term endolymphatic hydrops (ELH) has been coined 
(review: Schuknecht 1976; Foster & Breeze 2013). It has been sug-
gested that ELH is the cause of the symptoms MD patients show, 
but to date the precise role of ELH within the disease process has 
not been identified (Merchant et al. 2005; Berlinger 2011).
Gadolinium-enhanced inner-ear magnetic resonance imaging 
(MRI) in MD patients with intratympanically injected contrast 
agents has been demonstrated to enable the separate visualiza-
tion of endolymphatic and perilymphatic spaces in humans (Zou 
et al. 2005), and therefore the detection of ELH (Nakashima 
et al. 2007) as a method of ascertaining the diagnosis (Gürkov 
et al. 2011, 2012). It requires, however, a field-strength of at least 
3 T, is costly and not universally available. Before cochlear MRI 
became available, tone burst electrocochleography measure-
ments were the only available method to detect at least a surro-
gate of ELH or its underlying cause (review: Ferraro & Durrant 
2006): Summating potential amplitudes, normalized with the 
corresponding compound action potential amplitudes can indi-
cate changes in the symmetry of BM movements (review: Fer-
raro & Durrant 2006). It was suggested that ELH can dislocate 
the BM from its normal resting position, which will therefore 
give rise to increased summating potentials. In MD diagnostics, 
a summating potential/compound action potential ratio of more 
than 0.5 is considered abnormal and thus an indication for MD. 
Electrocochleography is a quick and inexpensive procedure and 
has been reported to be of at least equal sensitivity for the detec-
tion of cochlear ELH compared with inner-ear MRI (Hornibrook 
et al. 2015), but requires transtympanic positioning of recording 
electrodes for optimum signal to noise ratios, which is not toler-
ated by some patients.
As a consequence, noninvasive, cost-effective tests with high 
sensitivity and specifity for ELH are desirable. In this study, 
we therefore examine the suitability of otoacoustic emissions 
(OAEs) for ELH detection.
OAEs are sounds produced by the inner ear which can be 
measured with sensitive microphones in the ear canal. They 
result from the cochlea’s active, nonlinear processing of sound 
and occur spontaneously, or can be evoked with acoustic or 
electrical stimulation (see Shera 2004 for review). Ample evi-
dence is available in the literature demonstrating that OAEs are 
physiologically vulnerable and therefore reflect cochlear integ-
rity (Probst et al. 1987; Hauser et al. 1991; Reshef et al. 1993; 
Gorga et al. 1997).
OAEs are products of cochlear nonlinearities, predominantly 
generated in the outer hair cells (Kemp 1979, 1980; Wilson 
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1980; Siegel et al. 1982; Zurek et al. 1982; Brown et al. 1989; 
Verpy et al. 2008). Most cochlear nonlinearities can be reason-
ably approximated with a sigmoidal Boltzmann function and 
represent the transfer function of for example, the outer hair 
cell (OHC) mechano-electrical transducer (Santos-Sacchi 
1993). Active, nonlinear properties of the cochlea produce 
several even and odd orders of distortion product otoacoustic 
emissions (DPOAEs) when supplied with the sum of two sinu-
soidal acoustic stimuli. The levels of the two most prominent 









DPOAEs reflect different symmetric and antisymmetric proper-
ties of the cochlear transfer function: cubic DPOAEs are largest 
when the gain of the cochlear amplifier is maximized, whereas 
quadratic DPOAEs are largest when the cochlear transfer func-
tion saturates (Bian & Chen 2008). The levels of quadratic and 
cubic DPOAEs can be estimated by the absolute value of the 
second or third derivative of the Boltzmann function, respec-
tively (Frank et al. 1996, 1997; Lukashkin & Russell 2005; 
Abel et al. 2009). When the operating point (OP) is close to the 
inflection point (i.e., the point of the maximum slope) of the 
transfer function, cubic DPOAEs will show maximum levels. 
When the OP is shifted away from the inflection point (toward 
saturation), quadratic DPOAE levels grow larger while cubic 
DPOAE levels decrease (Drexl et al. 2012). It has been shown 
that electrically or acoustically induced shifts of the OP indeed 
result in changes of cubic and quadratic DPOAE levels as pre-
dicted by a Boltzmann simulation (Frank & Kössl 1996, 1997; 
Abel et al. 2009). It has been suggested that ELH leads, due to 
the increased endolymphatic volume and, presumably, conse-
quent displacement of the basilar membrane, to changed resting 
positions of the organ of Corti and thus the OP of the OHC 
transfer functions (Brown & Gibson 2011; Brown et al. 2013).
Experimental induction of ELH in animal models (e.g., by 
injection of artificial endolymph) causes typical changes of cubic 
and quadratic DPOAEs as predicted from OP shifts (Sirjani et al. 
2004). Since a similar DPOAE behavior can be expected in MD 
patients, given that ELH indeed causes OP shifts, several attempts 
have been made to find correlations between the presence of ELH 
and cubic DPOAE measurements (Rotter et al. 2008; Avan et al. 
2011; Brown & Gibson 2011). Cubic DPOAE mainly serve to 
register the cochlear hearing loss these patients present with, and 
MD patients are often not distinguishable from patients with com-
parable hearing impairments not related to MD (Harris & Probst 
1992; Pérez et al. 1997; Fetterman 2001; de Kleine et al. 2002).
Thus, exploiting the different behavior of simultaneously 
recorded cubic and quadratic DPOAE to changed OPs might 
represent a more suitable approach to detect pathologies associ-
ated with ELH.
There is also evidence from animal models that ELH leads 
to inner hair cell (IHC) and OHC loss (Megerian et al. 2008). 
OHC loss and an associated decrease in cochlear gain should 
impair the generation of both cubic and quadratic DPOAEs 
and lead to reduced levels of both DPOAE orders, but the pres-
ence of notches in DPOAE growth functions can also lead to 
differential changes in both DPOAE orders (Mills et al. 1993; 
Lukashkin et al. 2002). In addition, it is also feasible that OP 
shifts contribute to reduced DPOAE levels in MD patients in 
comparison to normal-hearing participants.
In this study, we therefore simultaneously recorded cubic 
and quadratic OAEs in normal-hearing participants and in the 





ratios to ensure that best ratios for both DPOAE orders were 
included in the measurements.
MATERIALS AND METHODS
A total of 77 patients was screened, and OAEs were ana-
lyzed in 32 patients with definite MD (according to the criteria 
reported in Monsell et al. 1995). Patients were enrolled when 
they had unilateral disease, two or more definitive episodes of 
vertigo with hearing loss, tinnitus, aural fullness, and no his-
tory of middle ear or neurological disorders. In 22 MD patients, 
the diagnosis of certain MD was confirmed by MRI of ELH 
(Nakashima et al. 2016). Forty five participants with normal 
hearing were also included in this study.
All experiments were approved by the ethics committee of 
the University Hospital of the Ludwig-Maximilians-University 
Munich, Germany, in agreement with the Code of Ethics of the 
World Medical Association (Declaration of Helsinki) for experi-
ments involving humans and all participants gave their written 
informed consent. Recordings were either carried out in a sound-
attenuated chamber (averaged noise floor between 1 and 8 kHz: 
28.8 ± 4.8 dB SPL) or in a quiet examination room fitted with 
a sound-attenuated door (averaged noise floor between 1 and 
8 kHz: 24.8 ± 5.5 dB SPL). Audiometric (at 0.5, 1, 2, 3, 4, and 
6 kHz) and tympanometric data were assessed for both groups. 
MD patients with a four-frequency (0.5, 1, 2, and 3 kHz) average 
hearing threshold of more than 40 dB HL were excluded from the 
study, as were healthy participants with average hearing thresh-
olds of more than 20 dB HL. Participants in both groups were 
also excluded when otoscopic or tympanometric assessment gave 
abnormal results. Tympanometric results were considered normal 
when the peak admittance was found to be between −150 and 
+25 daPa with peak levels between 0.2 and 1.5 millimhos. Before 
measurements, the ear canals of the participants were inspected 
by an otolaryngologist and cerumen was removed, if necessary. 
Participants were seated in a comfortable recliner during mea-
surements and were advised to remain as still and quiet as possible 
during measurements. DPOAEs were recorded with an Etymotic 
Research ER-10C DPOAE probe system (Etymōtic Research, 
Inc., Elk Grove Village, IL). Signal generation and data acquisi-
tion were carried out with a Fireface UC 24-bit external sound 
card (RME, Audio AG, Haimhausen, Germany), run at a sam-
pling rate of 44.1 kHz with a buffer size of 512 bits. The recorded 
signal was amplified 30 dB by the soundcard’s microphone pre-
amplifier, the built-in preamplifier of the ER-10C probe system 
was set to a gain of 0. The sound card was controlled by scripts 
written in MatLab 7.5 (MathWorks, Natick, MA). The Sound-
MexPro sound application (HörTech, Oldenburg, Germany) was 
employed to use low-latency multi-channel Audio Stream Input/
Output (ASIO) interfacing in Matlab. ER10C-14A Foam eartips 
(Etymōtic Research, Inc., Elk Grove Village, IL) were used to 
seal the probe into the ear canal of the participants. All analysis, 
statistics, and visualization were carried out in MatLab.
Stimuli were presented with duration of 0.5 second including 
a rise/fall time of 2 msec with a repetition rate of 1.5 Hz. Sound 
pressure levels were chosen between 50 and 65 dB SPL, and fre-
quencies were set between 1 and 8 kHz. Stimulus presentation 
and concurrent DPOAE recording was repeated between 16 and 
32 times depending on the number of rejected noisy averages. 
Recordings were rejected when the averaged noise floor surround-
ing the DPOAE spectral line exceeded sound pressure levels of −5 
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dB SPL. The noise floor was estimated by averaging the magni-
tudes of three spectral lines above and three below the actual OAE 
frequency spectral line. The recording stopped when 32 repetitions 
were recorded, or when at least 16 valid averages with a signal to 
noise ratio equal to or exceeding 6 dB were recorded, depending 
on whichever occurred earlier. Averaged data points not reaching 
a signal to noise ratio of 6 dB after 32 repetitions were not used 
for later calculation of interparticipant mean values. These proce-
dures kept the contamination of the signal with artifacts caused by 
swallowing, coughing etc. to a minimum.
Recorded signals were averaged in the time domain to 
reduce random noise, windowed with a Hann window, and then 
analyzed with a Fast Fourier Transform, where Fast Fourier 
Transform size was equal to the length of the recorded signal. 









, respectively, were then extracted from the real 
part of the spectrum.
Calibration of the sound system was carried out in situ, that 
is, stimuli were calibrated for constant sound pressure at the 
probe tip, not at the tympanic membrane, with the known draw-
back of sound pressure levels deviations due to standing waves 
at frequencies higher than 3 kHz (Siegel 1994). Please refer to 
Drexl et al. (2012) for details of the calibration procedure.
The following recording protocol was carried out in all 
participants:
 1. To assess the integrity of the DPOAE-generating mecha-









, were evoked with f
2
 
set to frequencies between 1 and 8 kHz and levels were 
set to l
1
 = 60 dB SPL, l
2
 = 50 dB SPL.









simultaneously recorded, while f
2
 was held constant at 
4 and 5 kHz, and f
1





changed from 1.1 to 1.6 in 0.04 steps, levels were set 
to l
1
 = 65 dB SPL, l
2
 = 65 dB SPL in normal-hearing 
participants, as well as in the affected and the unaffected 
ear of MD patients at fixed f
2
 frequencies of 4 and 5 kHz. 
As best ratios for cubic and quadratic DPOAEs are quite 





 ratios ensured that the individual best ratio was 
included in the recordings.
All statistical analysis was carried out with MatLab. Ratio and 
frequency curves were tested in separate, two-factor, mixed 
design analysis of variances for influences of f
2





 ratio (13 and 10 values, respectively) and the ear condition 
(normal hearing, MD affected, MD nonaffected), followed by a 
posthoc analysis. The interaction of these parameters was also 
tested. p values of the posthoc analysis were adjusted for multi-
ple comparisons according to the Holm-Bonferroni correction.
RESULTS
DPOAE-Grams
Cubic DPOAE-grams of normal-hearing participants (Fig. 1) 
were comparable with the results of similar measurements 
available in the literature (Moulin 2000; Drexl et al. 2012): they 
showed distinct level minima for DPOAEs evoked with f
2
 fre-
quencies in the region around 3kHz, followed by a recovery of 
DPOAE levels around f
2
 frequencies of about 5 kHz. DPOAE-
grams of the affected and unaffected ears of MD patients 
Fig. 1. DPOAE-grams of normal-hearing ears, and of the affected and unaffected ears of MD patients with f2 frequencies between 1 and 8 kHz in quarter-octave 
steps, primary tone levels l1 and l2.were 60 and 50 dB SPL, respectively. Bars represent means; error bars give the SE of the mean. Brackets indicate significant 
differences between pairs (post hoc analysis; *, **, ***p values smaller than 0.05, 0.01, and 0.001, respectively. p values were corrected for multiple compari-
sons. DPOAE indicates distortion product otoacoustic emission; MD, Ménière’s disease.
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(Fig. 1) shared the same qualitative features, albeit at reduced 
DPOAE levels. Statistical analysis revealed that there was an 
overall effect of the ear condition (F
2, 95





 = 34.10, p < 0.001) on cubic DPOAE 





 = 1.44, p = 0.079). Only 
the affected ears of MD patients showed significant differences 
to normal-hearing participants at all tested frequencies. Signifi-
cant differences between ears of normal-hearing participants 
and the nonaffected ears of MD patients, and the affected and 
unaffected ears of MD patients were only seen at a few fre-
quencies (see Fig. 1 for results of the posthoc analysis, p values 
adjusted according to the Holm-Bonferroni method).






Ears of Normal-Hearing Participants • In normal-hearing 





 ratios of about 1.2 (Bian & Chen 2008). Here, the mean 
best ratio was also 1.2 at f
2
 frequencies of 4 and 5 kHz, respec-
tively (Fig. 2A, B). The picture is quite different for quadratic 
DPOAEs in normal-hearing participants. As already reported 





 ratio do not show a distinct peak. In this study, 
quadratic DPOAE levels at both f
2
 frequencies showed maxi-




 ratio tested (1.1) and decreased 
steadily from there (Fig. 2C, D). Taken together, quadratic and 
cubic DPOAEs produced a specific pattern in normal-hearing 
participants: The cubic DPOAE levels at both f
2
 frequencies 





 ratios of up to about 1.35, where quadratic and cubic 




 ratios greater than this, 
quadratic DPOAE amplitudes remained equal-level or even 
exceeded cubic DPOAE levels
Ears of MD Patients • In both affected and unaffected ears of 
MD patients cubic DPOAE levels had, very similar to normal-




 ratio of about 
1.2 at both f
2
 frequencies, but maximum levels amplitudes were 
reduced by about 10 and 5 dB, respectively, in comparison to 
healthy ears (Fig. 2A, B). Quadratic DPOAEs of the affected 
and unaffected ears of MD patients resembled their counter-
parts in normal-hearing participants more closely and showed 
similar characteristics: quadratic DPOAE levels at both f
2
 fre-









 ratios exceeding 1.4, quadratic and cubic amplitudes were 
about iso-level.
For cubic DPOAEs, at f
2
 = 4 kHz, there was no overall effect 
of the ear condition (F
2, 46
 = 2.3, p = 0.112), but there was an 
Fig. 2. Cubic (A, B) and quadratic (C, D) DPOAE levels as function of f2/f1 ratio between 1.1 and 1.55 of normal-hearing ears, and of the affected and unaffected 
ears of MD patients at f2 = 4 kHz (A, C) and f2 = 5 kHz (B, D). Bars represent means; error bars give the SE of the mean. Brackets indicate significant differences 
between pairs (post hoc analysis; *, **p values smaller than 0.05, and 0.01, respectively. p values were corrected for multiple comparisons. DPOAE indicates 
distortion product otoacoustic emission; MD, Ménière’s disease.
Copyright © 2017 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
46  DREXL ET AL. / EAR & HEARING, VOL. 39, NO. 1, 42–47






 = 27.12, p < 0.001) on 
DPOAE level. There was also a significant interaction effect 






 = 2.79, p < 0.001), 
A posthoc analysis revealed statistical differences between nor-





ratios between 1.15 and 1,2, respectively, but not between unaf-
fected and affected MD ears.
For cubic DPOAEs at f
2
 = 5 kHz, an overall effect of the ear 
condition (F
2,66
 = 6.37, p = 0.003) could be found, and there 






 = 60.77, p < 0.001) 
on cubic DPOAE level. There was also a significant interac-






 = 44.50, 
p < 0.001). A posthoc analysis revealed statistical differences 





between 1.1 and 1.3.
In quadratic DPOAEs, at f
2





 ratio was found (F
9,369
 = 13.56, p < 0.001) and there was 







 = 44.50; p < 0.001), but no overall effect of the ear 
condition (F
2,41
 = 1.10; p = 0.340) on quadratic DPOAE levels.
At f
2





on quadratic DPOAE levels (F
2,60
 = 3.13; p = 0.051) and no 






 = 1.16). 




 ratio on DPOAE 
levels (F
9,540
 = 26.15, p < 0.001). At both f
2
 frequencies, posthoc 
analyses revealed no significant differences.
DISCUSSION
The experiments in the present study are based on the 
hypothesis that in MD patients, the presence of ELH leads 
to shifts of cochlear transfer function OPs which change the 
relation between cubic and quadratic DPOAE levels when 
compared with normal-hearing participants: In particular, OP 
shifts away from the point of inflection of the cochlear trans-
fer function increase the quadratic DPOAEs, and decrease 
cubic DPOAE. Therefore, if ELH shifts the OP away from its 
typical resting position near the point of inflection, quadratic 
DPOAEs should be increased. We could not confirm that qua-
dratic DPOAEs at given primary tone frequencies and levels 
are significantly larger in MD patients compared with normal-
hearing participants. Averaged quadratic DPOAE levels in the 
affected ear of MD patients are slightly (but not statistically 
significant) reduced and cubic DPOAE levels in the affected 
ear of MD patients are significantly reduced relative to normal-
hearing participants. A comparison of simultaneously evoked 
cubic and quadratic DPOAEs reveals the real nature of DPOAE 
generation changes in MD patients: OHC function impairment 
should affect cubic and quadratic DPOAE generation, albeit by 
different amounts due to the different growth function charac-
teristics (Bian & Chen 2008), if we accept that the sources for 
the nonlinear distortion component for both cubic and quadratic 
DPOAEs are near the f
2
 representation and thus the same. It 
has been shown that manipulations affecting OHC motility 
(Frank & Kössl 1996) can indeed decrease cubic and quadratic 
DPOAEs, explained by a linearization of the cochlear transfer 
function, but at certain time points differential changes of cubic 
and quadratic DPOAEs occur, explained by OP shifts. Remov-
ing a dominant source of cochlear nonlinearity (Verpy et al. 
2008) results in complete loss of DPOAEs, regardless the order. 
In the case of OHC impairment, the typical DPOAE pattern seen 
by simultaneously evoking quadratic and cubic DPOAE should 
simply be shifted to lower levels, but in the presence of notches 
in DPOAE growth functions differential changes can also occur 
(Mills et al. 1993; Lukashkin et al. 2002). Notches in human 
DPOAE growth functions are not as consistently found as in 
rodents, but can sometimes be observed (Whitehead 1998).
In our results, quadratic DPOAE levels are fairly conserved 
across experimental groups and are only slightly reduced, 
whereas cubic DPOAE levels are significantly reduced in the 
affected ears of MD patients, compared with normal-hearing 
participants. This seemingly paradoxical behavior can be 
explained by assuming that reductions of quadratic DPOAE lev-
els caused by OHC impairment are, at least in part, compensated 
by an enhancement of quadratic DPOAE amplitudes caused by 
the suggested OP shift related to ELH or its underlying mecha-
nism in MD patients. In addition, a more global sensitivity 
change might also cause differential alterations of cubic and 
quadratric DPOAEs in the presence of DPOAE growth function 
notches. Also, the slopes of quadratic DPOAE growth functions 
in humans (but also in rodents) are typically shallower than of 
cubic DPOAEs (Frank & Kössl 1996; Lukashkin et al. 2002; 
Bian & Chen 2008), and, as a consequence, are less sensitive to 
gain changes. Alternatively, ELH or its underlying mechanism 
might also induce changes of DPOAE fine structure. While the 
most prominent differences across experimental groups in our 
results occurred near the optimum ratio for DPOAE genera-
tion, it has been shown that the DPOAE reflection component is 
relatively small compared with the distortion component in the 
range of the primary tone levels we used (Mauermann & Koll-
meier 2004), rendering a major contribution from fine structure 
changes unlikely.
While significant differences were found between affected 
ears of MD patients with ears of normal-hearing participants, 
there were only few stimulus configurations where statistically 
significant differences between unaffected and affected ears 
of MD patients existed. Our patient population consisted of 
patients with unilateral MD, defined as the absence of audio-
vestibular symptoms and functional deficits in the contralateral 
ear. However, recent evidence from inner-ear MRI studies has 
shown that the prevalence of bilateral ELH in patients with uni-
lateral MD may be as high as 65% (Pyykkö et al. 2013), offer-
ing a possible explanation for the observed effects. In summary, 
we could identify the relatively good preservation of quadratic 
DPOAEs in relation to a significant reduction of cubic DPOAE 
levels in the affected ears of MD patients as a potential non-
invasive diagnostic approach in the early stage of suspected 
MD. Future studies validating the differential diagnostic power 
of this parameter in control groups with nonhydropic forms of 
hearing loss are now warranted.
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